Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Long-term versus short-term androgen deprivation combined with high-dose conformal radiotherapy (HDCRT) for patients with localized prostate cancer

Next Previous
X
Search
Trial Profile

Long-term versus short-term androgen deprivation combined with high-dose conformal radiotherapy (HDCRT) for patients with localized prostate cancer

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Apr 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bicalutamide (Primary) ; Flutamide (Primary) ; Goserelin (Primary)
  • Indications Adenocarcinoma; Prostate cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms AADLPC

    • Most Recent Events

    • 12 Apr 2022 10-year final results assessing whether long-term androgen deprivation is superior to short-term androgen deprivation when combined with high-dose radiotherapy published in the Lancet Oncology
    • 01 Jul 2021 Results (n=154)of post hoc analysis the effect of serum testosterone levels and testosterone recovery on clinical outcome in a subgroup of localized prostate cancer patients treated in the long-term arm, published in the Radiotherapy and Oncology
    • 07 Jun 2011 Interim results presented at the 47th Annual Meeting of the American Society of Clinical Oncology.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top